0001209191-20-045698.txt : 20200807 0001209191-20-045698.hdr.sgml : 20200807 20200807174133 ACCESSION NUMBER: 0001209191-20-045698 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200805 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Suri Anish CENTRAL INDEX KEY: 0001739130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 201085637 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-05 0 0001645460 Cue Biopharma, Inc. CUE 0001739130 Suri Anish C/O CUE BIOPHARMA, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 President and CSO Common Stock 2020-08-05 4 M 0 800 6.42 A 35358 D Common Stock 2020-08-05 4 S 0 800 20.01 D 34558 D Stock Option (right to buy) 6.42 2020-08-05 4 M 0 800 0.00 D 2029-03-06 Common Stock 800 145000 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019. /s/ Anish Suri by Mark Busch, attorney-in-fact 2020-08-07